271 related articles for article (PubMed ID: 34667145)
1. XBP1 regulates the protumoral function of tumor-associated macrophages in human colorectal cancer.
Zhao Y; Zhang W; Huo M; Wang P; Liu X; Wang Y; Li Y; Zhou Z; Xu N; Zhu H
Signal Transduct Target Ther; 2021 Oct; 6(1):357. PubMed ID: 34667145
[TBL] [Abstract][Full Text] [Related]
2. The Ap-2α/Elk-1 axis regulates Sirpα-dependent tumor phagocytosis by tumor-associated macrophages in colorectal cancer.
Wang X; Luo X; Chen C; Tang Y; Li L; Mo B; Liang H; Yu S
Signal Transduct Target Ther; 2020 Apr; 5(1):35. PubMed ID: 32296015
[TBL] [Abstract][Full Text] [Related]
3. X-box Binding Protein 1 Regulates Unfolded Protein, Acute-Phase, and DNA Damage Responses During Regeneration of Mouse Liver.
Argemí J; Kress TR; Chang HCY; Ferrero R; Bértolo C; Moreno H; González-Aparicio M; Uriarte I; Guembe L; Segura V; Hernández-Alcoceba R; Ávila MA; Amati B; Prieto J; Aragón T
Gastroenterology; 2017 Apr; 152(5):1203-1216.e15. PubMed ID: 28082079
[TBL] [Abstract][Full Text] [Related]
4. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.
Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q
J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013
[TBL] [Abstract][Full Text] [Related]
5. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression.
Liu Q; Yang C; Wang S; Shi D; Wei C; Song J; Lin X; Dou R; Bai J; Xiang Z; Huang S; Liu K; Xiong B
Cell Commun Signal; 2020 Mar; 18(1):51. PubMed ID: 32228612
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of anti-VEGF receptor 2 therapy targeting for M2-tumor-associated macrophages in colorectal cancer.
Min AKT; Mimura K; Nakajima S; Okayama H; Saito K; Sakamoto W; Fujita S; Endo H; Saito M; Saze Z; Momma T; Ohki S; Kono K
Cancer Immunol Immunother; 2021 Feb; 70(2):289-298. PubMed ID: 32705303
[TBL] [Abstract][Full Text] [Related]
7. Transcription of the NKG2D ligand MICA is suppressed by the IRE1/XBP1 pathway of the unfolded protein response through the regulation of E2F1.
Obiedat A; Seidel E; Mahameed M; Berhani O; Tsukerman P; Voutetakis K; Chatziioannou A; McMahon M; Avril T; Chevet E; Mandelboim O; Tirosh B
FASEB J; 2019 Mar; 33(3):3481-3495. PubMed ID: 30452881
[TBL] [Abstract][Full Text] [Related]
8. Deregulation of XBP1 expression contributes to myocardial vascular endothelial growth factor-A expression and angiogenesis during cardiac hypertrophy in vivo.
Duan Q; Ni L; Wang P; Chen C; Yang L; Ma B; Gong W; Cai Z; Zou MH; Wang DW
Aging Cell; 2016 Aug; 15(4):625-33. PubMed ID: 27133203
[TBL] [Abstract][Full Text] [Related]
9. Thapsigargin promotes colorectal cancer cell migration through upregulation of lncRNA MALAT1.
Jiang X; Li D; Wang G; Liu J; Su X; Yu W; Wang Y; Zhai C; Liu Y; Zhao Z
Oncol Rep; 2020 Apr; 43(4):1245-1255. PubMed ID: 32323831
[TBL] [Abstract][Full Text] [Related]
10. XBP1-s promotes colorectal cancer cell proliferation by inhibiting TAp73 transcriptional activity.
Ji H; Huang C; Wu S; Kasim V
Biochem Biophys Res Commun; 2019 Jan; 508(1):203-209. PubMed ID: 30473215
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer.
Zhu X; Liang R; Lan T; Ding D; Huang S; Shao J; Zheng Z; Chen T; Huang Y; Liu J; Pathak JL; Wei H; Wei B
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36104099
[TBL] [Abstract][Full Text] [Related]
12. Androgen modulation of XBP1 is functionally driving part of the AR transcriptional program.
Stelloo S; Linder S; Nevedomskaya E; Valle-Encinas E; de Rink I; Wessels LFA; van der Poel H; Bergman AM; Zwart W
Endocr Relat Cancer; 2020 Feb; 27(2):67-79. PubMed ID: 31804970
[TBL] [Abstract][Full Text] [Related]
13. Endoplasmic reticulum stress in bipolar disorder? - BiP and CHOP gene expression- and XBP1 splicing analysis in peripheral blood.
Bengesser SA; Reininghaus EZ; Dalkner N; Birner A; Hohenberger H; Queissner R; Fellendorf F; Platzer M; Pilz R; Hamm C; Rieger A; Kapfhammer HP; Mangge H; Reininghaus B; Meier-Allard N; Stracke A; Fuchs R; Holasek S
Psychoneuroendocrinology; 2018 Sep; 95():113-119. PubMed ID: 29843019
[TBL] [Abstract][Full Text] [Related]
14.
Bartoszewska S; Cabaj A; Dąbrowski M; Collawn JF; Bartoszewski R
FASEB J; 2019 Oct; 33(10):11541-11554. PubMed ID: 31314593
[TBL] [Abstract][Full Text] [Related]
15. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
Schürch CM; Roelli MA; Forster S; Wasmer MH; Brühl F; Maire RS; Di Pancrazio S; Ruepp MD; Giger R; Perren A; Schmitt AM; Krebs P; Charles RP; Dettmer MS
Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231
[No Abstract] [Full Text] [Related]
16. Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC.
Huang C; Ou R; Chen X; Zhang Y; Li J; Liang Y; Zhu X; Liu L; Li M; Lin D; Qiu J; Liu G; Zhang L; Wu Y; Tang H; Liu Y; Liang L; Ding Y; Liao W
J Exp Clin Cancer Res; 2021 Sep; 40(1):304. PubMed ID: 34583750
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
18. Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages.
Wang D; Wang X; Si M; Yang J; Sun S; Wu H; Cui S; Qu X; Yu X
Cancer Lett; 2020 Apr; 474():36-52. PubMed ID: 31931030
[TBL] [Abstract][Full Text] [Related]
19. CD47 Blockade Inhibits Tumor Progression through Promoting Phagocytosis of Tumor Cells by M2 Polarized Macrophages in Endometrial Cancer.
Gu S; Ni T; Wang J; Liu Y; Fan Q; Wang Y; Huang T; Chu Y; Sun X; Wang Y
J Immunol Res; 2018; 2018():6156757. PubMed ID: 30525058
[TBL] [Abstract][Full Text] [Related]
20. The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death.
Pozzi C; Cuomo A; Spadoni I; Magni E; Silvola A; Conte A; Sigismund S; Ravenda PS; Bonaldi T; Zampino MG; Cancelliere C; Di Fiore PP; Bardelli A; Penna G; Rescigno M
Nat Med; 2016 Jun; 22(6):624-31. PubMed ID: 27135741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
